Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to examine the level of ovarian response and the
pregnancy rates among poor ovarian responders treated with a novel treatment protocol with
150μg corifollitropin alfa followed by 300IU hMG in a long GnRH agonist protocol.